[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 162, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL", "age": 59, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 3332915, "exercisedValue": 0, "unexercisedValue": 3757481}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 56, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2936973, "exercisedValue": 0, "unexercisedValue": 520353}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 706970, "exercisedValue": 0, "unexercisedValue": 4750777}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 58, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lynda  Harris", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 35, "title": "Chief Business Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 73, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.22, "open": 10.24, "dayLow": 9.84, "dayHigh": 10.27, "regularMarketPreviousClose": 10.22, "regularMarketOpen": 10.24, "regularMarketDayLow": 9.84, "regularMarketDayHigh": 10.27, "payoutRatio": 0.0, "beta": 0.739, "forwardPE": -6.7843804, "volume": 1760918, "regularMarketVolume": 1760918, "averageVolume": 1954149, "averageVolume10days": 1426720, "averageDailyVolume10Day": 1426720, "bid": 9.96, "ask": 10.04, "bidSize": 2, "askSize": 1, "marketCap": 987497600, "fiftyTwoWeekLow": 6.66, "fiftyTwoWeekHigh": 18.9, "allTimeHigh": 63.41, "allTimeLow": 2.55, "priceToSalesTrailing12Months": 6.9166055, "fiftyDayAverage": 10.2881, "twoHundredDayAverage": 12.60675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1856591232, "profitMargins": -0.56061, "floatShares": 105406228, "sharesOutstanding": 98848611, "sharesShort": 20224758, "sharesShortPriorMonth": 21588277, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.20459999, "heldPercentInsiders": 0.16826001, "heldPercentInstitutions": 0.88452005, "shortRatio": 11.35, "shortPercentOfFloat": 0.33330002, "impliedSharesOutstanding": 98848611, "bookValue": 1.494, "priceToBook": 6.686747, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -80040000, "trailingEps": -0.81, "forwardEps": -1.4725, "enterpriseToRevenue": 13.004, "enterpriseToEbitda": -20.673, "52WeekChange": -0.18846464, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 9.99, "targetHighPrice": 35.0, "targetLowPrice": 12.0, "targetMeanPrice": 28.0, "targetMedianPrice": 31.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 288208992, "totalCashPerShare": 1.458, "ebitda": -89807000, "totalDebt": 169804992, "quickRatio": 6.406, "currentRatio": 6.66, "totalRevenue": 142772000, "debtToEquity": 115.001, "revenuePerShare": 1.454, "returnOnAssets": -0.19221, "returnOnEquity": -0.45916, "grossProfits": 114873000, "freeCashflow": -56190248, "operatingCashflow": -85377000, "revenueGrowth": 14.716, "grossMargins": 0.80459, "ebitdaMargins": -0.62902, "operatingMargins": -1.6366299, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -2.250494, "regularMarketPrice": 9.99, "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "marketState": "CLOSED", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1954149, "fiftyTwoWeekLowChange": 3.33, "fiftyTwoWeekLowChangePercent": 0.5, "fiftyTwoWeekRange": "6.66 - 18.9", "fiftyTwoWeekHighChange": -8.91, "fiftyTwoWeekHighChangePercent": -0.47142857, "fiftyTwoWeekChangePercent": -18.846464, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "earningsCallTimestampStart": 1762781400, "earningsCallTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.81, "epsForward": -1.4725, "epsCurrentYear": -1.8, "priceEpsCurrentYear": -5.55, "fiftyDayAverageChange": -0.29810047, "fiftyDayAverageChangePercent": -0.028975269, "twoHundredDayAverageChange": -2.6167498, "twoHundredDayAverageChangePercent": -0.20756736, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2026-01-30", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "postMarketChangePercent": 0.20020479, "postMarketPrice": 10.01, "postMarketChange": 0.020000458, "regularMarketChange": -0.2300005, "regularMarketDayRange": "9.84 - 10.27", "corporateActions": [], "postMarketTime": 1769816507, "regularMarketTime": 1769806801, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]